Effect of Lovastatin on Serum Lipids in Primary Hypercholesterolemia
Korean Circulation Journal
;
: 322-327, 1991.
Article
in Korean
| WPRIM
| ID: wpr-102753
ABSTRACT
10 Patients with primary hypercholesterolemia were treated for 12 weeks with lovastation(20mg t.i.d). Lovastatin reduced mean total and low density lipoprotein cholesterol by 43% and 57% respectively(p<0.001). High density lipoprotein cholesterol and triglyceride levels were unchanged by the drug. Adverse effects attributable to lovastatin were not observed. Thus lovastatin is considered as an effective lipid lowering agent for the treatment of primary moderate hypercholesterolemia.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Triglycerides
/
Lovastatin
/
Hypercholesterolemia
/
Cholesterol, HDL
/
Cholesterol, LDL
Limits:
Humans
Language:
Korean
Journal:
Korean Circulation Journal
Year:
1991
Type:
Article
Similar
MEDLINE
...
LILACS
LIS